Anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2 SUPPL. 2, 2010, Pages

  Simons, F Estelle R ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

adrenaline; allergic reaction; Anaphylaxis; basophil; epinephrine; Fc lunate RI; food allergy; H1 antihistamine; histamine; IgE; mast cell; medication allergy; tryptase; venom allergy

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALCOHOL; ALLERGEN; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; BETA LACTAM ANTIBIOTIC; CETUXIMAB; CHONDROITIN SULFATE; CONTRAST MEDIUM; CYCLOOXYGENASE 1 INHIBITOR; DEXTRAN; FOLIC ACID; GELATIN; GLUCOCORTICOID; HEPARIN; HYMENOPTERA VENOM; IBUPROFEN; IMMUNOGLOBULIN E; INFLIXIMAB; INSECT VENOM; LATEX; LOPERAMIDE; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; OPIATE DERIVATIVE; TRYPTASE; VACCINE; VANCOMYCIN;

ABDOMINAL CRAMP; ANAPHYLAXIS; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOINJECTOR; BRONCHOSPASM; COMORBIDITY; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DYSPNEA; EGG; EMERGENCY CARE; ENZYME BLOOD LEVEL; EVIDENCE BASED MEDICINE; EXERCISE; FATALITY; GASTROINTESTINAL SYMPTOM; HEAT; HIGH RISK PATIENT; HUMAN; HYPOXEMIA; IMMUNOMODULATION; INCIDENCE; INCONTINENCE; LABORATORY TEST; MUSCLE HYPOTONIA; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SENSITIZATION; SKIN TEST; STRIDOR; SUNLIGHT; SYNCOPE; ULTRAVIOLET RADIATION; VOMITING; WHEEZING;

ALLERGENS; ANAPHYLAXIS; ANIMALS; DESENSITIZATION, IMMUNOLOGIC; EPINEPHRINE; HISTAMINE ANTAGONISTS; HUMANS; MONITORING, PHYSIOLOGIC; PATIENT EDUCATION AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 76749114684     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.12.981     Document Type: Article

References (200)

1. Simons F.E.R. Anaphylaxis. 2008 Mini-primer on allergic and immunologic diseases. J Allergy Clin Immunol 121 suppl (2008) S402-S407
2. Sampson H.A., Munoz-Furlong A., Campbell R.L., Adkinson Jr. N.F., Bock S.A., Branum A., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117 (2006) 391-397
3. Lieberman P., Camargo Jr. C.A., Bohlke K., Jick H., Miller R.L., Sheikh A., et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97 (2006) 596-602
4. Yocum M.W., Butterfield J.H., Klein J.S., Volcheck G.W., Schroeder D.R., and Silverstein M.D. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 104 (1999) 452-456
5. Simons F.E.R., Peterson S., and Black C.D. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying the epidemiology of anaphylaxis. J Allergy Clin Immunol 110 (2002) 647-651
6. Bohlke K., Davis R.L., DeStefano F., Marcy S.M., Braun M.M., and Thompson R.S. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 113 (2004) 536-542
7. Helbling A., Hurni T., Mueller U.R., and Pichler W.J. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 34 (2004) 285-290
8. Poulos L.M., Waters A.M., Correll P.K., Loblay R.H., and Marks G.B. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 120 (2007) 878-884
9. Camargo Jr. C.A., Clark S., Kaplan M.S., Lieberman P., and Wood R.A. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol 120 (2007) 131-136
10. Decker W.W., Campbell R.L., Manivannan V., Luke A., St Sauver J.L., Weaver A., et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 122 (2008) 1161-1165
11. Lin R.Y., Anderson A.S., Shah S.N., and Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Ann Allergy Asthma Immunol 101 (2008) 387-393
12. Sheikh A., Hippisley-Cox J., Newton J., and Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. J R Soc Med 101 (2008) 139-143
13. Ross M.P., Ferguson M., Street D., Klontz K., Schroeder T., and Luccioli S. Analysis of food-allergic and anaphylactic events in the National Electronic Injury Surveillance System. J Allergy Clin Immunol 121 (2008) 166-171
14. Liew W.K., Williamson E., and Tang M.L.K. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 123 (2009) 434-442
15. Simons F.E.R., and Sampson H.A. Anaphylaxis epidemic: fact or fiction?. J Allergy Clin Immunol 122 (2008) 1166-1168
16. Clark S., Gaeta T.J., Kamarthi G.S., and Camargo C.A. ICD-9-CM coding of emergency department visits for food and insect sting allergy. Ann Epidemiol 16 (2006) 696-700
17. Gaeta T.J., Clark S., Pelletier A.J., and Camargo C.A. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Ann Allergy Asthma Immunol 98 (2007) 360-365
18. Sampson H.A., Mendelson L., and Rosen J.P. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 327 (1992) 380-384
19. Bock S.A., Munoz-Furlong A., and Sampson H.A. Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 119 (2007) 1016-1018
20. Pumphrey R.S.H., and Gowland M.H. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. J Allergy Clin Immunol 119 (2007) 1018-1019
21. Greenberger P.A., Rotskoff B.D., and Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 98 (2007) 252-257
22. Shen Y., Li L., Grant J., Rubio A., Zhao Z., Zhang X., et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic Sci Int 186 (2009) 1-5
23. Simon M.R., and Mulla Z.D. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 63 (2008) 1077-1083
24. Simons F.E.R. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 124 (2009) 625-636
25. Lieberman P.L. Anaphylaxis. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S.T., Lemanske Jr. R.F., and Simons F.E.R. (Eds). Middleton's allergy: principles and practice. 7th ed (2009), Mosby, Inc, St Louis 1027-1049
26. Sampson H.A., and Burks A.W. Adverse reactions to foods. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S.T., Lemanske Jr. R.F., and Simons F.E.R. (Eds). Middleton's allergy: principles and practice. 7th ed. (2009), Mosby, Inc, St Louis 1139-1167
27. Shek L.P.C., and Lee B.W. Food allergy in Asia. Curr Opin Allergy Clin Immunol 6 (2006) 197-201
28. Astier C., Moneret-Vautrin D.-A., Puillandre E., and Bihain B.E. First case report of anaphylaxis to quinoa, a novel food in France. Allergy 64 (2009) 819-820
29. Kleinheinz A., Lepp U., Hausen B.M., Petersen A., and Becker W.M. Anaphylactic reaction to (mixed) fruit juice containing dragon fruit. J Allergy Clin Immunol 124 (2009) 841-842
30. Commins S.P., Satinover S.M., Hosen J., Mozena J., Borish L., Lewis B.D., et al. Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol 123 (2009) 426-433
31. Ohgiya Y., Arakawa F., Akiyama H., Yoshioka Y., Hayashi Y., Sakai S., et al. Molecular cloning, expression, and characterization of a major 38-kd cochineal allergen. J Allergy Clin Immunol 123 (2009) 1157-1162
32. Sanchez-Borges M., Iraola V., Fernandez-Caldas E., Capriles-Hulett A., and Caballero-Fonseca F. Dust mite ingestion-associated, exercise-induced anaphylaxis. J Allergy Clin Immunol 120 (2007) 714-716
33. Petithory J.-C. [New data on anisakiasis]. Bull Acad Natl Med 191 (2007) 53-65
34. Celik W., Pichler W.J., and Adkinson Jr. N.F. Drug allergy. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S.T., Lemanske Jr. R.F., and Simons F.E.R. (Eds). Middleton's allergy: principles and practice. 7th ed. (2009), Mosby, Inc, St Louis 1205-1226
35. Novembre E., Mori F., Pucci N., Bernardini R., and Romano A. Cefaclor anaphylaxis in children. Allergy 64 (2009) 1233-1235
36. Berges-Gimeno M.P., and Martin-Lazaro J. Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better?. Curr Allergy Asthma Rep 7 (2007) 35-40
37. Perez-Calderon R., and Gonzalo-Garijo M.A. Anaphylaxis due to loperamide. Allergy 59 (2004) 369-370
38. Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358 (2008) 2457-2467
39. Nishitani N., Adachi A., Fukumoto T., Ueno M., Fujiwara N., Ogura K., et al. Folic acid-induced anaphylaxis showing cross-reactivity with methotrexate: a case report and review of the literature. Int J Dermatol 48 (2009) 522-524
40. Ji K.-M., Li M., Chen J.-J., Zhan Z.-K., and Liu Z.-G. Anaphylactic shock and lethal anaphylaxis caused by Houttuynia Cordata injection, a herbal treatment in China. Allergy 64 (2009) 816-817
41. Harper N.J.N., Dixon T., Dugue P., Edgar D.M., Fay A., Gooi H.C., et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64 (2009) 199-211
42. Brockow K., Romano A., Aberer W., Bircher A.J., Barbaud A., Bonadonna P., et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media-a European multicenter study. Allergy 64 (2009) 234-241
43. Chung C.H., Mirakhur B., Chan E., Le Q.-T., Berlin J., Morse M., et al. Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose. N Engl J Med 358 (2008) 1109-1117
44. Cheifetz A., Smedley M., Martin S., Reiter M., Leone G., Mayer L., et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 98 (2003) 1315-1324
45. Limb S.L., Starke P.R., Lee C.E., and Chowdhury B.A. Delayed onset and protracted progression of anaphylaxis after omalizumab administration in patients with asthma. J Allergy Clin Immunol 120 (2007) 1378-1381
46. Rezvani M., and Bernstein D.I. Anaphylactic reactions during immunotherapy. Immunol Allergy Clin North Am 27 (2007) 295-307
47. Rodriguez-Perez N., Ambriz-Moreno M., Canonica G.W., and Penagos M. Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Ann Allergy Asthma Immunol 101 (2008) 304-310
48. Kelso J.M., Li J.T., Nicklas R.A., Bernstein D.I., Blessing-Moore J., Cox L., et al. Adverse reactions to vaccines. Ann Allergy Asthma Immunol 103 suppl (2009) S1-S14
49. Slade B.A., Leidel L., Vellozzi C., Woo E.J., Hua W., Sutherland A., et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 302 (2009) 750-757
50. Erlewyn-Lajeunesse M., Brathwaite N., Lucas J.S.A., and Warner J.O. Recommendations for the administration of influenza vaccine in children allergic to egg. BMJ 339 (2009) b3680
51. Zanoni G., Puccetti A., Dolcino M., Simone R., Peretti A., Ferro A., et al. Dextran-specific IgG response in hypersensitivity reactions to measles-mumps-rubella vaccine. J Allergy Clin Immunol 122 (2008) 1233-1235
52. Golden D.B.K. Insect allergy. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S.T., Lemanske Jr. R.F., and Simons F.E.R. (Eds). Middleton's allergy: principles and practice. 7th ed. (2009), Mosby, Inc, Vol. 2. St Louis 1005-1017
53. Bilo M.B., and Bonifazi F. The natural history and epidemiology of insect venom allergy: clinical implications. Clin Exp Allergy 39 (2009) 1467-1476
54. Freeman T.M. Clinical practice. Hypersensitivity to hymenoptera stings. N Engl J Med 351 (2004) 1978-1984
55. Tankersley M.S. The stinging impact of the imported fire ant. Curr Opin Allergy Clin Immunol 8 (2008) 354-359
56. Shek L.P.C., Ngiam N.S.P., and Lee B.W. Ant allergy in Asia and Australia. Curr Opin Allergy Clin Immunol 4 (2004) 325-328
57. Peng Z., Beckett A.N., Engler R.J., Hoffman D.R., Ott N.L., and Simons F.E.R. Immune responses to mosquito saliva in 14 individuals with acute systemic allergic reactions to mosquito bites. J Allergy Clin Immunol 114 (2004) 1189-1194
58. Yunginger J.W. Natural rubber latex allergy. In: Adkinson Jr. N.F., Bochner B.S., Busse W.W., Holgate S.T., Lemanske Jr. R.F., and Simons F.E.R. (Eds). Middleton's allergy: principles and practice. 7th ed. Vol. 2 (2009), Mosby, Inc, St Louis 1019-1026
59. Basagana M., Bartolome B., Pastor C., Torres F., Alonso R., Vivanco F., et al. Allergy to human seminal fluid: cross-reactivity with dog dander. J Allergy Clin Immunol 121 (2008) 233-239
60. Gawlik R., and Pitsch T. Allergy to horse. Ann Allergy Asthma Immunol 96 (2006) 631
61. Du Toit G. Food-dependent exercise-induced anaphylaxis in childhood. Pediatr Allergy Immunol 18 (2007) 455-463
62. Cooper D.M., Radom-Aizik S., Schwindt C., and Zaldivar Jr. F. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 103 (2007) 700-709
63. Greenberger P.A. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 27 (2007) 273-293
64. Akin C., Scott L.M., Kocabas C.N., Kushnir-Sukhov N., Brittain E., Noel P., et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood 110 (2007) 2331-2333
65. Gonzalez de Olano D., de la Hoz Caballer B., Nunez Lopez R., Sanchez Munoz L., Cuevas Agustin M., Dieguez M.C., et al. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 37 (2007) 1547-1555
66. Brockow K., Jofer C., Behrendt H., and Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 63 (2008) 226-232
67. Muller U.R. Elevated baseline serum tryptase, mastocytosis and anaphylaxis. Clin Exp Allergy 39 (2009) 620-622
68. Simons F.E.R., Frew A.J., Ansotegui I.J., Bochner B.S., Finkelman F., Golden D.B.K., et al. Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol 120 suppl (2007) S2-S24
69. Simons F.E.R. Anaphylaxis, killer allergy: long-term management in the community. J Allergy Clin Immunol 117 (2006) 367-377
70. Peavy R.D., and Metcalfe D.D. Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol 8 (2008) 310-315
71. Metcalfe D.D., Peavy R.D., and Gilfillan A.M. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 124 (2009) 639-646
72. Kalesnikoff J., and Galli S.J. New developments in mast cell biology. Nat Immunol 9 (2008) 1215-1223
73. Finkelman F.D. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 120 (2007) 506-515
74. Khodoun M., Strait R., Orekov T., Hogan S., Karasuyama H., Herbert D.R., et al. Peanuts can contribute to anaphylactic shock by activating complement. J Allergy Clin Immunol 123 (2009) 342-351
75. Schwartz L.B. Heparin comes clean. N Engl J Med 358 (2008) 2505-2509
76. Bansal G., Xie Z., Rao S., Nocka K.H., and Druey K.M. Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13. Nat Immunol 9 (2008) 73-80
77. Baba Y., Nishida K., Fujii Y., Hirano T., Hikida M., and Kurosaki T. Essential function for the calcium sensor STIM1 in mast cell activation and anaphylactic responses. Nat Immunol 9 (2008) 81-88
78. Schwartz L.B. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 26 (2006) 451-463
79. Komarow H.D., Hu Z., Brittain E., Uzzaman A., Gaskins D., and Metcalfe D.D. Serum tryptase levels in atopic and nonatopic children. J Allergy Clin Immunol 124 (2009) 845-848
80. Vadas P., Gold M., Perelman B., Liss G., Lack G., Blyth T., et al. Platelet-activating factor, PAF acetylhydrolase and severe anaphylaxis. N Engl J Med 358 (2008) 28-35
81. Treudler R., Kozovska Y., and Simon J.C. Severe immediate type hypersensitivity reactions in 105 German adults: when to diagnose anaphylaxis. J Investig Allergol Clin Immunol 18 (2008) 52-58
82. Ono E., Taniguchi M., Mita H., Fukutomi Y., Higashi N., Miyazaki E., et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy 39 (2009) 72-80
83. Pushparaj P.N., Tay H.K., H'ng S.C., Pitman N., Xu D., McKenzie A., et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106 (2009) 9773-9778
84. Stone S.F., Cotterell C., Isbister G.K., and Holdgate A. Brown SGA, for the Emergency Department Anaphylaxis Investigators. Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. J Allergy Clin Immunol 124 (2009) 786-792
85. Olivera A., Mizugishi K., Tikhonova A., Ciaccia L., Odom S., Proia R.L., et al. The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26 (2007) 287-297
86. Jensen B.M., Beaven M.A., Iwaki S., Metcalfe D.D., and Gilfillan A.M. Concurrent inhibition of Kit- and Fc epsilon RI-mediated signaling: coordinated suppression of mast cell activation. J Pharmacol Exp Ther 324 (2008) 128-138
87. Mazuc E., Villoutreix B.O., Malbec O., Roumier T., Fleury S., Leonetti J.P., et al. A novel drug-like spleen tyrosine kinase binder prevents anaphylactic shock when administered orally. J Allergy Clin Immunol 122 (2008) 188-194
88. Bochner B.S. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors. Clin Exp Allergy 39 (2009) 317-324
89. Chang T.W., and Shiung Y.Y. Anti-IgE as a mast cell-stabilizing therapeutic agent. J Allergy Clin Immunol 117 (2006) 1203-1212
90. Plager D.A., Weiss E.A., Kephart G.M., Mocharla R.M., Matsumoto R., Checkel J.L., et al. Identification of basophils by a mAb directed against pro-major basic protein 1. J Allergy Clin Immunol 117 (2006) 626-634
91. Korhonen H., Fisslthaler B., Moers A., Wirth A., Habermehl D., Wieland T., et al. Anaphylactic shock depends on endothelial Gq/G11. J Exp Med 206 (2009) 411-420
92. Yamashita Y., Charles N., Furumoto Y., Odom S., Yamashita T., Gilfillan A.M., et al. Cutting edge: genetic variation influences Fc epsilonRI-induced mast cell activation and allergic responses. J Immunol 179 (2007) 740-743
93. Sampson H.A., Munoz-Furlong A., Bock S.A., Schmitt C., Bass R., Chowdhury B.A., et al. Symposium on the definition and management of anaphylaxis: summary report. J Allergy Clin Immunol 115 (2005) 584-591
94. Simons F.E.R. Anaphylaxis in infants: can recognition and management be improved?. J Allergy Clin Immunol 120 (2007) 537-540
95. Greenhawt M.J., Singer A.M., and Baptist A.P. Food allergy and food allergy attitudes among college students. J Allergy Clin Immunol 124 (2009) 323-327
96. Chaudhuri K., Gonzales J., Jesurun C.A., Ambat M.T., and Mandal-Chaudhuri S. Anaphylactic shock in pregnancy: a case study and review of the literature. Int J Obstet Anesth 17 (2008) 350-357
97. Triggiani M., Patella V., Staiano R.I., Granata F., and Marone G. Allergy and the cardiovascular system. Clin Exp Immunol 153 suppl 1 (2008) 7-11
98. Mueller U.R. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 7 (2007) 337-341
99. Lang D.M. Do beta-blockers really enhance the risk of anaphylaxis during immunotherapy?. Curr Allergy Asthma Rep 8 (2008) 37-44
100. Bonadonna P., Perbellini O., Passalacqua G., Caruso B., Colarossi S., Dal Fior D., et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol 123 (2009) 680-686
101. Bonadonna P., Zanotti R., Pagani M., Caruso B., Perbellini O., Colarossi S., et al. How much specific is the association between Hymenoptera venom allergy and mastocytosis?. Allergy 64 (2009) 1379-1382
102. Metcalfe D.D., and Schwartz L.B. Assessing anaphylactic risk? Consider mast cell clonality. J Allergy Clin Immunol 123 (2009) 687-688
103. Rueff F., Przybilla B., Bilo M.B., Muller U., Scheipl F., Aberer W., et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity. J Allergy Clin Immunol 124 (2009) 1047-1054
104. Hershko A.Y., Dranitzki Z., Ulmanski R., Levi-Schaffer F., and Naparstek Y. Constitutive hyperhistaminaemia: a possible mechanism for recurrent anaphylaxis. Scand J Clin Lab Invest 61 (2001) 449-452
105. Summers C.W., Pumphrey R.S., Woods C.N., McDowell G., Pemberton P.W., and Arkwright P.D. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol 121 (2008) 632-638
106. Mullins R.J. Anaphylaxis: risk factors for recurrence. Clin Exp Allergy 33 (2003) 1033-1040
107. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction?. Curr Opin Allergy Clin Immunol 4 (2004) 285-290
108. Varshney P., Steele P.H., Vickery B.P., Bird J.A., Thyagarajan A., Scurlock A.M., et al. Adverse reactions during peanut oral immunotherapy home dosing. J Allergy Clin Immunol 124 (2009) 1351-1352
109. Hofmann A., and Burks A.W. Pollen food syndrome: update on the allergens. Curr Allergy Asthma Rep 8 (2008) 413-417
110. Dowden A.M., Rullo O.J., Aziz N., Fasano M.B., Chatila T., and Ballas Z.K. Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks. J Allergy Clin Immunol 124 (2009) 1111-1113
111. Nowak-Wegrzyn A., Assa'ad A.H., Bahna S.L., Bock S.A., Sicherer S.H., and Teuber S.S. Work Group report: oral food challenge testing. J Allergy Clin Immunol 123 suppl (2009) S365-S383
112. Sicherer S.H., and Sampson H.A. Food allergy: recent advances in pathophysiology and treatment. Ann Rev Med 60 (2009) 261-277
113. Wang J., Godbold J.H., and Sampson H.A. Correlation of serum allergy (IgE) tests performed by different assay systems. J Allergy Clin Immunol 121 (2008) 1219-1224
114. Pereira B., Venter C., Grundy J., Clayton C.B., Arshad S.H., and Dean T. Prevalence of sensitization to food allergens, reported adverse reaction to foods, food avoidance, and food hypersensitivity among teenagers. J Allergy Clin Immunol 116 (2005) 884-892
115. Ko J., Lee J.I., Munoz-Furlong A., Li X., and Sicherer S.H. Use of complementary and alternative medicine by food-allergic patients. Ann Allergy Asthma Immunol 97 (2006) 365-369
116. Sturm G.J., Kranzelbinder B., Sturm E.M., Heinemann A., Groselj-Strele A., and Aberer W. The basophil activation test in the diagnosis of allergy: technical issues and critical factors. Allergy 64 (2009) 1319-1326
117. Steckelbroeck S., Ballmer-Weber B.K., and Vieths S. Potential, pitfalls, and prospects of food allergy diagnostics with recombinant allergens or synthetic sequential epitopes. J Allergy Clin Immunol 121 (2008) 1323-1330
118. Lin J., Bardina L., Shreffler W.G., Andreae D.A., Ge Y., Wang J., et al. Development of a novel peptide microarray for large-scale epitope mapping of food allergens. J Allergy Clin Immunol 124 (2009) 315-322
119. Cerecedo I., Zamora J., Shreffler W.G., Lin J., Bardina L., Dieguez M.C., et al. Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol 122 (2008) 589-594
120. Naisbitt D.J., Sanderson L.S., Meng X., Stachulski A.V., Clarke S.E., and Park B.K. Investigation of the immunogenicity of diclofenac and diclofenac metabolites. Toxicol Lett 168 (2007) 45-50
121. Malbran A., Yeyati E., Rey G.L., and Galassi N. Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients. Clin Exp Immunol 147 (2007) 99-105
122. Sharif S., and Goldberg B. Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment. Ann Allergy Asthma Immunol 98 (2007) 563-566
123. Golden D.B.K., Kelly D., Hamilton R.G., Wang N.Y., and Kagey-Sobotka A. Dialyzed venom skin tests for identifying yellow jacket-allergic patients not detected using standard venom. Ann Allergy Asthma Immunol 102 (2009) 47-50
124. Golden D.B.K. Insect sting allergy and venom immunotherapy: a model and a mystery. J Allergy Clin Immunol 115 (2005) 439-447
125. Golden D.B.K., Breisch N.L., Hamilton R.G., Guralnick M.W., Greene A., Craig T.J., et al. Clinical and entomological factors influence the outcome of sting challenge studies. J Allergy Clin Immunol 117 (2006) 670-675
126. Sturm G.J., Heinemann A., Schuster C., Wiednig M., Groselj-Strele A., Sturm E.M., et al. Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy. Allergy 62 (2007) 884-889
127. de Graaf D.C., Aerts M., Danneels E., and Devreese B. Bee, wasp and ant venomics pave the way for a component-resolved diagnosis of sting allergy. J Proteonomics 72 (2009) 145-154
128. Loibl M., Schwarz S., Ring J., Halle M., and Brockow K. Definition of an exercise intensity threshold in a challenge test to diagnose food-dependent exercise-induced anaphylaxis. Allergy 64 (2009) 1560-1561
129. Anonymous. The Food Allergy and Anaphylaxis Management Act of 2009. Senate Bill 456, introduced into the United States Senate. Available at: http://thomas.loc.gov. Accessed October 20, 2009.
130. Oude Elberink J.N. Significance and rationale of studies of health-related quality of life in anaphylactic disorders. Curr Opin Allergy Clin Immunol 6 (2006) 298-302
131. Herbert L.J., and Dahlquist L.M. Perceived history of anaphylaxis and parental overprotection, autonomy, anxiety, and depression in food allergic young adults. J Clin Psychol Med Settings 15 (2008) 261-269
132. Pieretti M.M., Chung D., Pacenza R., Slotkin T., and Sicherer S.H. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J Allergy Clin Immunol 124 (2009) 337-341
133. Boyano-Martinez T., Garcia-Ara C., Pedrosa M., Diaz-Pena J.M., and Quirce S. Accidental allergic reactions in children allergic to cow's milk proteins. J Allergy Clin Immunol 123 (2009) 883-888
134. Burks A.W., Laubach S., and Jones S.M. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 121 (2008) 1344-1350
135. Wood R.A. Food-specific immunotherapy: past, present, and future. J Allergy Clin Immunol 121 (2008) 336-337
136. Plaut M., Sawyer R.T., and Fenton M.J. Summary of the 2008 National Institute of Allergy and Infectious Diseases-US Food and Drug Administration Workshop on Food Allergy Clinical Trial Design. J Allergy Clin Immunol 124 (2009) 671-678
137. Skripak J.M., Nash S.D., Rowley H., Brereton N.H., Oh S., Hamilton R.G., et al. A randomized, double-blind, placebo-controlled study of milk oral immunotherapy for cow's milk allergy. J Allergy Clin Immunol 122 (2008) 1154-1160
138. Narisety S.D., Skripak J.M., Steele P., Hamilton R.G., Matsui E.C., Burks A.W., et al. Open-label maintenance after milk oral immunotherapy for IgE-mediated cow's milk allergy. J Allergy Clin Immunol 124 (2009) 610-612
139. Longo G., Barbi E., Berti I., Meneghetti R., Pittalis A., Ronfani L., et al. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J Allergy Clin Immunol 121 (2008) 343-347
140. Jones S.M., Pons L., Roberts J.L., Scurlock A.M., Perry T.T., Kulis M., et al. Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 124 (2009) 292-300
141. Hofmann A.M., Scurlock A.M., Jones S.M., Palmer K.P., Lokhnygina Y., Steele P.H., et al. Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124 (2009) 286-291
142. Srivastava K.D., Qu C., Zhang T., Goldfarb J., Sampson H.A., and Li X.M. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+T cells. J Allergy Clin Immunol 123 (2009) 443-451
143. Leung D.Y.M., Sampson H.A., Yunginger J.W., Burks Jr. A.W., Schneider L.C., Wortel C.H., et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 348 (2003) 986-993
144. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am 29 (2009) 585-606
145. Golden D.B.K., Kagey-Sobotka A., Norman P.S., Hamilton R.G., and Lichtenstein L.M. Outcomes of allergy to insect stings in children, with and without venom immunotherapy. N Engl J Med 351 (2004) 668-674
146. Bilo M.B., Severino M., Cilia M., Pio A., Casino G., Ferrarini E., et al. The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts. Ann Allergy Asthma Immunol 103 (2009) 57-61
147. Gonzalez de Olano D., Alvarez-Twose I., Esteban-Lopez M.I., Sanchez-Munoz L., de Durana M.D., Vega A., et al. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis. J Allergy Clin Immunol 121 (2008) 519-526
148. Bonadonna P., Zanotti R., Caruso B., Castellani L., Perbellini O., Colarossi S., et al. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy. J Allergy Clin Immunol 121 (2008) 256-257
149. Kontou-Fili K. High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Allergy 63 (2008) 376-378
150. Golden D.B.K., Kelly D., Hamilton R.G., and Craig T.J. Venom immunotherapy reduces large local reactions to insect stings. J Allergy Clin Immunol 123 (2009) 1371-1375
151. Warrier P., and Casale T.B. Omalizumab in idiopathic anaphylaxis. Ann Allergy Asthma Immunol 102 (2009) 257-258
152. Carter M.C., Robyn J.A., Bressler P.B., Walker J.C., Shapiro G.G., and Metcalfe D.D. Omalizumab for the treatment of unprovoked anaphylaxis in patients with systemic mastocytosis. J Allergy Clin Immunol 119 (2007) 1550-1551
153. Simons F.E.R. Anaphylaxis: evidence-based long-term risk reduction in the community. Immunol Allergy Clin North Am 27 (2007) 231-248
154. Soar J., Pumphrey R., Cant A., Clarke S., Corbett A., Dawson P., et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 77 (2008) 157-169
155. Brown S.G.A., Mullins R.J., and Gold M.S. Anaphylaxis: diagnosis and management. Med J Aust 185 (2006) 283-289
156. Westfall T.C., and Westfall D.P. Adrenergic agonists and antagonists. In: Brunton L.L., Lazo J.S., and Parker K.L. (Eds). Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. (2006), McGraw-Hill Companies, Inc, New York 237-247
157. Brown S.G.A., Blackman K.E., Stenlake V., and Heddle R.J. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 21 (2004) 149-154
158. Simons F.E.R. First-aid treatment of anaphylaxis to food: focus on epinephrine. J Allergy Clin Immunol 113 (2004) 837-844
159. Kemp S.F., Lockey R.F., and Simons F.E.R. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 63 (2008) 1061-1070
160. Sheikh A., Shehata Y.A., Brown S.G.A., and Simons F.E.R. Adrenaline for the treatment of anaphylaxis: Cochrane systematic review. Allergy 64 (2009) 204-212
161. Ridella M., Bagdure S., Nugent K., and Cevik C. Kounis syndrome following beta-lactam antibiotic use: review of literature. Inflamm Allergy Drug Targets 8 (2009) 11-16
162. Lieberman P. Use of epinephrine in the treatment of anaphylaxis. Curr Opin Allergy Clin Immunol 3 (2003) 313-318
163. Joint Task Force on Practice Parameters, American Academy of Allergy, Asthma and Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, and Asthma and Immunology. The diagnosis and management of anaphylaxis: an updated practice parameter. J Allergy Clin Immunol 115 suppl (2005) S483-S523
164. Muraro A., Roberts G., Clark A., Eigenmann P.A., Halken S., Lack G., et al. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 62 (2007) 857-871
165. Alrasbi M., and Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 62 (2007) 838-841
166. Pumphrey R.S.H. Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112 (2003) 451-452
167. Tole J.W., and Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am 27 (2007) 309-326
168. Ellis A.K., and Day J.H. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Ann Allergy Asthma Immunol 98 (2007) 64-69
169. Scranton S.E., Gonzalez E.G., and Waibel K.H. Incidence and characteristics of biphasic reactions after allergen immunotherapy. J Allergy Clin Immunol 123 (2009) 493-498
170. Song T.T., Nelson M.R., Chang J.H., Engler R.J.M., and Chowdhury B.A. Adequacy of the epinephrine autoinjector needle length in delivering epinephrine to the intramuscular tissues. Ann Allergy Asthma Immunol 94 (2005) 539-542
171. Stecher D., Bulloch B., Sales J., Schaefer C., and Keahey L. Epinephrine auto-injectors: is needle length adequate for delivery of epinephrine intramuscularly?. Pediatrics 124 (2009) 65-70
172. Simons F.E.R., Gu X., Silver N.A., and Simons K.J. EpiPen Jr versus EpiPen in young children weighing 15-30 kg at risk for anaphylaxis. J Allergy Clin Immunol 109 (2002) 171-175
173. Mehr S., Robinson M., and Tang M. Doctor-how do I use my EpiPen?. Pediatr Allergy Immunol 18 (2007) 448-452
174. Simons F.E.R., Lieberman P.L., Read Jr. E.J., and Edwards E.S. Hazards of unintentional injection of epinephrine from auto-injectors: a systematic review. Ann Allergy Asthma Immunol 102 (2009) 282-287
175. Simons F.E.R., Edwards E.S., Read Jr. E.J., Clark S., and Liebelt E.L. Voluntarily reported unintentional injections from epinephrine auto-injectors. J Allergy Clin Immunol 125 (2010) 419-423
176. Jarvinen K.M., Sicherer S.H., Sampson H.A., and Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol 122 (2008) 133-138
177. Manivannan V., Campbell R.L., Bellolio M.F., Stead L.G., Li J.T.C., and Decker W.W. Factors associated with repeated use of epinephrine for the treatment of anaphylaxis. Ann Allergy Asthma Immunol 103 (2009) 395-400
178. Simons F.E.R., Clark S., and Camargo C.A. Anaphylaxis in the community: learning from the survivors. J Allergy Clin Immunol 124 (2009) 301-306
179. Simons F.E.R., and World Allergy Organization. Epinephrine auto-injectors: first-aid treatment still out of reach for many at risk of anaphylaxis in the community. Ann Allergy Asthma Immunol 102 (2009) 403-409
180. Johnson T.L., and Parker A.L. Rates of retrieval of self-injectable epinephrine prescriptions: a descriptive report. Ann Allergy Asthma Immunol 97 (2006) 694-697
181. Rawas-Qalaji M., Simons F.E.R., Collins D., and Simons K.J. Long-term stability of epinephrine dispensed in unsealed syringes for the first-aid treatment of anaphylaxis. Ann Allergy Asthma Immunol 102 (2009) 500-503
182. 1-antihistamines. N Engl J Med 351 (2004) 2203-2217
183. 1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 62 (2007) 830-837
184. Starke P.R., Weaver J., and Chowdhury B.A. Boxed warning added to promethazine labeling for pediatric use. N Engl J Med 352 (2005) 2653
185. Choo K.J.L., Simons F.E.R., and Sheikh A. Glucocorticoids for the treatment of anaphylaxis (protocol). Cochrane Database Syst Rev 1 (2009) CD007596
186. American Academy of Allergy Asthma and Immunology Board of Directors. Anaphylaxis in schools and other child-care settings. J Allergy Clin Immunol 102 (1998) 173-176
187. Nurmatov U., Worth A., and Sheikh A. Anaphylaxis management plans for the acute and long-term management of anaphylaxis: a systematic review. J Allergy Clin Immunol 122 (2008) 353-361
188. Young M.C., Munoz-Furlong A., and Sicherer S.H. Management of food allergies in schools: a perspective for allergists. J Allergy Clin Immunol 124 (2009) 175-182
189. Munoz-Furlong A. Food allergy in schools: concerns for allergists, pediatricians, parents, and school staff. Ann Allergy Asthma Immunol 93 (2004) S47-S50
190. Cox L., Platts-Mills T.A.E., Finegold I., Schwartz L.B., Simons F.E.R., and Wallace D.V. American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol 120 (2007) 1373-1377
191. Lieberman P., Decker W., Camargo Jr. C.A., O'Connor R., Oppenheimer J., and Simons F.E. SAFE: a multidisciplinary approach to anaphylaxis education in the emergency department. Ann Allergy Asthma Immunol 98 (2007) 519-523
192. Campbell R.L., Luke A., Weaver A.L., St Sauver J.L., Bergstralh E.J., Li J.T., et al. Prescriptions for self-injectable epinephrine and follow-up referral in emergency department patients presenting with anaphylaxis. Ann Allergy Asthma Immunol 101 (2008) 631-636
193. Ben-Shoshan M., Kagan R., Primeau M.N., Alizadehfar R., Verreault N., Yu J.W., et al. Availability of the epinephrine autoinjector at school in children with peanut allergy. Ann Allergy Asthma Immunol 100 (2008) 570-575
194. Norton L., Dunn Galvin A., and Hourihane J.O. Allergy rescue medication in schools: modeling a new approach. J Allergy Clin Immunol 122 (2008) 209-210
195. Oswalt M.L., and Kemp S.F. Anaphylaxis: office management and prevention. Immunol Allergy Clin North Am 27 (2007) 177-191
196. Wheeler D.W., Carter J.J., Murray L.J., Degnan B.A., Dunling C.P., Salvador R., et al. The effect of drug concentration expression on epinephrine dosing errors: a randomized trial. Ann Intern Med 148 (2008) 11-14
197. Mullner M., Urbanek B., Havel C., Losert H., Waechter F., and Gamper G. Vasopressors for shock. Cochrane Database Syst Rev 3 (2004) CD003709
198. Gueugniaud P.Y., David J.S., Chanzy E., Hubert H., Dubien P.Y., Mauriaucourt P., et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med 359 (2008) 21-30
199. Choong K., Bohn D., Fraser D.D., Gaboury I., Hutchison J.S., Joffe A.R., et al. Vasopressin in pediatric vasodilatory shock. Am J Respir Crit Care Med 180 (2009) 632-639
200. Simons F.E.R. Emergency treatment of anaphylaxis. BMJ 336 (2008) 1141-1142